Teladoc Health, Inc. (
sold 2,254 shares of the business's stock in a transaction dated Thursday, March 2nd. The shares were sold at an average price of $25.36, for a total value of $57,161.44. Following the completion of the transaction, the chief marketing officer now directly owns 35,188 shares in the company, valued at $892,367.68. The sale was disclosed in a legal filing with the SEC, which is available through
the SEC website
Teladoc Health Trading Up 5.7 %
opened at $26.88 on Friday. Teladoc Health, Inc. has a 12 month low of $21.60 and a 12 month high of $77.50. The company has a 50-day moving average price of $27.22 and a 200 day moving average price of $28.05. The company has a quick ratio of 2.99, a current ratio of 3.13 and a debt-to-equity ratio of 0.25.
Teladoc Health (
) last issued its quarterly earnings results on Wednesday, February 22nd. The health services provider reported ($0.23) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.04. Teladoc Health had a negative return on equity of 3.62% and a negative net margin of 567.53%. The firm had revenue of $637.71 million for the quarter, compared to the consensus estimate of $633.71 million. As a group, research analysts expect that Teladoc Health, Inc. will post -1.41 EPS for the current fiscal year.
Analyst Ratings Changes
Several equities analysts have recently issued reports on TDOC shares. Citigroup reduced their target price on Teladoc Health from $33.00 to $30.00 and set a 'neutral' rating for the company in a report on Tuesday, February 28th. Deutsche Bank Aktiengesellschaft dropped their price objective on Teladoc Health from $31.00 to $27.00 and set a 'hold' rating on the stock in a research note on Monday, February 27th. Royal Bank of Canada reiterated an 'outperform' rating and issued a $35.00 price objective on shares of Teladoc Health in a research note on Thursday, February 23rd.
upgraded Teladoc Health to a 'sell' rating in a research note on Friday, February 24th. Finally, JPMorgan Chase & Co. dropped their price objective on Teladoc Health from $35.00 to $33.00 and set a 'neutral' rating on the stock in a research note on Monday, February 27th. One research analyst has rated the stock with a sell rating, nineteen have issued a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat, Teladoc Health currently has an average rating of 'Hold' and a consensus target price of $36.96.
Institutional Investors Weigh In On Teladoc Health
Hedge funds and other institutional investors have recently modified their holdings of the business. IFP Advisors Inc raised its holdings in shares of Teladoc Health by 6.4% in the third quarter. IFP Advisors Inc now owns 6,286 shares of the health services provider's stock worth $349,000 after buying an additional 380 shares during the period. Canada Pension Plan Investment Board increased its holdings in Teladoc Health by 274.6% during the 3rd quarter. Canada Pension Plan Investment Board now owns 23,600 shares of the health services provider's stock worth $598,000 after purchasing an additional 17,300 shares during the period. Vontobel Holding Ltd. increased its holdings in Teladoc Health by 0.8% during the 3rd quarter. Vontobel Holding Ltd. now owns 104,140 shares of the health services provider's stock worth $2,639,000 after purchasing an additional 854 shares during the period. State of New Jersey Common Pension Fund D increased its holdings in Teladoc Health by 29.5% during the 2nd quarter. State of New Jersey Common Pension Fund D now owns 110,953 shares of the health services provider's stock worth $3,685,000 after purchasing an additional 25,292 shares during the period. Finally, Daiwa Securities Group Inc. increased its holdings in Teladoc Health by 11.8% during the 3rd quarter. Daiwa Securities Group Inc. now owns 9,075 shares of the health services provider's stock worth $230,000 after purchasing an additional 957 shares during the period. 84.14% of the stock is currently owned by hedge funds and other institutional investors.
Teladoc Health Company Profile
Teladoc Health, Inc engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure.
Receive News & Ratings for Teladoc Health Daily
- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with
MarketBeat.com's FREE daily email newsletter